SCHEMBL29644471

SCHEMBL29644471

Cc1cc(NCc2ccc(S(C)(=O)=O)cc2)c2nc(C)c(-c3ccc4c(c3)c(C)nn4C)n2n1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 18/20 0.44
PI4KA P42356 3/20 0.39
PTGS2 P35354 1/20 0.38
GHSR Q92847 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20528824 1.00 PI4KB (0.44) PI4KBPI4KAPTGS2GHSR
SCHEMBL21628164 0.87 PI4KB (0.45) PI4KBPI4KA
SCHEMBL21628161 0.86 PI4KB (0.49) PI4KBPI4KA
SCHEMBL29644484 0.86 PI4KB (0.49) PI4KBPI4KA
SCHEMBL29644496 0.85 PI4KB (0.54) PI4KBPI4KA
SCHEMBL20528858 0.85 PI4KB (0.54) PI4KBPI4KA
SCHEMBL20528846 0.84 PI4KB (0.42) PI4KBPI4KA
SCHEMBL29644511 0.84 PI4KB (0.42) PI4KBPI4KA
SCHEMBL20528862 0.81 PI4KB (0.45) PI4KBPI4KA
SCHEMBL29644505 0.81 PI4KB (0.45) PI4KBPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676485-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2026-01-14 EP claimed
WO-2024184442-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2024-09-12 WO claimed
EP-4028131-A1 HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY CUROVIR AB (SE) 2022-07-20 EP claimed
CN-110520424-B Heteroaromatic compounds for therapy 库洛维公司 2022-06-21 CN claimed
EP-4676485-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2026-01-14 EP disclosed
WO-2024184442-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2024-09-12 WO disclosed